Early Adjuvant Results A Major Boost For Verzenio
Commercially Important Indication
Pioneering results in early disease could prove significant for market prospects for Lilly’s CDK4/6 breast cancer drug.
Pioneering results in early disease could prove significant for market prospects for Lilly’s CDK4/6 breast cancer drug.